Urology · Lafayette, LA
NPI
1215934187
Since 2005
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1000 W Pinhook Rd, Suite 304
Lafayette, LA, 70503
Phone (337) 289-9155
Groups this clinician bills Medicare through
Medicare paid, 2024
$622K
36,170 services
Medicare patients, 2024
1,604
Average age 74
Drug cost, 2024
$700K
5,213 prescriptions
Company payments, 2025
$1,705
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by William B Roth was code J0585 (injection, onabotulinumtoxina, 1 unit), 2,000 times for 13 patients. In total William B Roth billed 36,170 services in 145 codes, and Medicare paid $622K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-02-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 2,000 | 13 | $4.99 | $9,974 |
| 99214 Office E&M - Established | Office | 1,178 | 949 | $90.91 | $107K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 965 | 813 | $12.63 | $12K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 922 | 165 | $46.35 | $43K |
| 81003 Clinical Chemistry | Office | 918 | 678 | $2.19 | $2,012 |
| 36415 Venipuncture Blood Collection | Office | 572 | 431 | $8.65 | $4,948 |
| 99213 Office E&M - Established | Office | 534 | 451 | $60.69 | $32K |
| 84153 Clinical Chemistry | Office | 496 | 382 | $17.93 | $8,894 |
| 81001 Clinical Chemistry | Office | 459 | 338 | $3.08 | $1,413 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 325 | 117 | $36.26 | $12K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 270 | 58 | $46.52 | $13K |
| 51798 Ultrasound - Nonspecific | Office | 260 | 234 | $7.89 | $2,051 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 244 | 61 | $0.32 | $78.53 |
| 96372 Injection Administration | Office | 227 | 88 | $9.91 | $2,250 |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 201 | 179 | $42.58 | $8,558 |
By year: 2022 $665K for 30,804 services; 2023 $628K for 33,783 services; 2024 $622K for 36,170 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 918 | 678 | $2.19 | $2,012 |
| 36415 Venipuncture Blood Collection | 572 | 431 | $8.65 | $4,948 |
| 84153 Clinical Chemistry | 496 | 382 | $17.93 | $8,894 |
| 81001 Clinical Chemistry | 459 | 338 | $3.08 | $1,413 |
| 84403 Clinical Chemistry | 149 | 114 | $25.29 | $3,768 |
| 87084 Bacterial Culture | 109 | 81 | $26.34 | $2,871 |
| 85027 Blood Count | 82 | 62 | $6.27 | $514 |
| 80053 Clinical Chemistry | 73 | 65 | $10.23 | $746 |
| 82670 Clinical Chemistry | 71 | 53 | $27.38 | $1,944 |
| G0416 Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 61 | 60 | $146.33 | $8,926 |
Medicare prescription drug claims, 2024
In 2024, the drug William B Roth prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,174 prescriptions and refills. In total William B Roth wrote 5,213 Medicare prescriptions that cost $700K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,174 | 2,286 | 265 | $13K |
| Finasteride Generic | 419 | 937 | 103 | $5,905 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 398 | 447 | 153 | $13K |
| Oxybutynin Chloride Generic | 310 | 546 | 78 | $3,530 |
| Testosterone Cypionate Generic | 303 | 465 | 86 | $12K |
| Gemtesa Vibegron | 210 | 276 | 42 | $131K |
| Ciprofloxacin Hcl Generic | 206 | 214 | 166 | $1,792 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 188 | 313 | 65 | $3,540 |
| Myrbetriq Mirabegron | 177 | 238 | 44 | $107K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 124 | 124 | 100 | $945 |
| Anastrozole Generic | 123 | 262 | 37 | $468 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 117 | 145 | 60 | $683 |
| Levofloxacin Generic | 114 | 114 | 96 | $459 |
| Imipramine Hcl Generic | 112 | 196 | 27 | $1,997 |
| Cephalexin Generic | 99 | 111 | 36 | $1,294 |
Brand drugs: - claims; generic drugs: 4,592 claims; opioid claims: 191.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid William B Roth $1,705 ($1,705 in general payments such as food, travel and fees) from 14 companies. The largest payer was Coloplast Corp with $550.
| Company | Payments | Amount |
|---|---|---|
| Coloplast Corp | 11 | $550 |
| Endo USA, Inc. | 14 | $398 |
| Calyxo, Inc. | 2 | $265 |
| Abbvie Inc. ABBV | 9 | $168 |
| Teleflex LLC TFX | 1 | $56.63 |
| Laborie Medical Technologies Corp. | 1 | $53 |
| Boston Scientific Corporation BSX | 1 | $50.39 |
| Dendreon Pharmaceuticals LLC | 2 | $43.99 |
| Janssen Biotech, Inc. JNJ | 2 | $38.92 |
| Astellas Pharma US Inc 4503.T | 2 | $32.63 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.